These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 25736524)
1. Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants. Patel M; Kaufman DA Expert Opin Biol Ther; 2015 Apr; 15(4):595-600. PubMed ID: 25736524 [TBL] [Abstract][Full Text] [Related]
2. Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants. Shah PS; Kaufman DA Cochrane Database Syst Rev; 2009 Apr; (2):CD006449. PubMed ID: 19370635 [TBL] [Abstract][Full Text] [Related]
3. Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates. Weisman LE; Thackray HM; Garcia-Prats JA; Nesin M; Schneider JH; Fretz J; Kokai-Kun JF; Mond JJ; Kramer WG; Fischer GW Antimicrob Agents Chemother; 2009 Jul; 53(7):2879-86. PubMed ID: 19380597 [TBL] [Abstract][Full Text] [Related]
4. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Weisman LE; Thackray HM; Steinhorn RH; Walsh WF; Lassiter HA; Dhanireddy R; Brozanski BS; Palmer KG; Trautman MS; Escobedo M; Meissner HC; Sasidharan P; Fretz J; Kokai-Kun JF; Kramer WG; Fischer GW; Mond JJ Pediatrics; 2011 Aug; 128(2):271-9. PubMed ID: 21788224 [TBL] [Abstract][Full Text] [Related]
5. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. DeJonge M; Burchfield D; Bloom B; Duenas M; Walker W; Polak M; Jung E; Millard D; Schelonka R; Eyal F; Morris A; Kapik B; Roberson D; Kesler K; Patti J; Hetherington S J Pediatr; 2007 Sep; 151(3):260-5, 265.e1. PubMed ID: 17719934 [TBL] [Abstract][Full Text] [Related]
6. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Bloom B; Schelonka R; Kueser T; Walker W; Jung E; Kaufman D; Kesler K; Roberson D; Patti J; Hetherington S; Pediatr Infect Dis J; 2005 Oct; 24(10):858-66. PubMed ID: 16220082 [TBL] [Abstract][Full Text] [Related]
7. Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature. Weisman LE Arch Pediatr; 2007 Sep; 14 Suppl 1():S31-4. PubMed ID: 17939955 [TBL] [Abstract][Full Text] [Related]
12. Specific immune globulin therapy for prevention of nosocomial staphylococcal bloodstream infection in premature infants: not what we hoped for! de la Morena MT J Pediatr; 2007 Sep; 151(3):232-4. PubMed ID: 17719927 [No Abstract] [Full Text] [Related]
13. Probiotics for prevention of necrotizing enterocolitis in preterm infants. AlFaleh K; Anabrees J Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307 [TBL] [Abstract][Full Text] [Related]
14. [Preventive antibiotic administration for prevention of nosocomial septicemia in very small premature infants (VLBW infants)--preventive vancomycin administration against infections with coagulase negative streptococci--prevention of translocation with oral cefixime therapy in intestinal colonization with pathogenic gram-negative pathogens]. Möller JC; Rossa M; Nachtrodt G; Richter A; Tegtmeyer FK Klin Padiatr; 1993; 205(3):140-4. PubMed ID: 8350584 [TBL] [Abstract][Full Text] [Related]
15. Is bloodstream infection preventable among premature infants? A tale of two cities. Aly H; Herson V; Duncan A; Herr J; Bender J; Patel K; El-Mohandes AA Pediatrics; 2005 Jun; 115(6):1513-8. PubMed ID: 15930211 [TBL] [Abstract][Full Text] [Related]
16. Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants. Capparelli EV; Bloom BT; Kueser TJ; Oelberg DG; Bifano EM; White RD; Schelonka RL; Pearlman SA; Patti J; Hetherington SV Antimicrob Agents Chemother; 2005 Oct; 49(10):4121-7. PubMed ID: 16189088 [TBL] [Abstract][Full Text] [Related]
18. Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants. Robinson J Evid Based Child Health; 2014 Sep; 9(3):672-4. PubMed ID: 25236308 [TBL] [Abstract][Full Text] [Related]
19. Prevention of neonatal late-onset sepsis associated with the removal of percutaneously inserted central venous catheters in preterm infants. Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG Pediatr Crit Care Med; 2011 Jul; 12(4):445-8. PubMed ID: 21263371 [TBL] [Abstract][Full Text] [Related]
20. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. Akin IM; Atasay B; Dogu F; Okulu E; Arsan S; Karatas HD; Ikinciogullari A; Turmen T Am J Perinatol; 2014 Dec; 31(12):1111-20. PubMed ID: 24839144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]